SEARCH

SEARCH BY CITATION

References

  • Aliyev A., Chen S. G., Seyidova D., Smith M. A., Perry G., De La Torre J. and Aliev G. (2005) Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. J. Neurol. Sci. 229–230, 285292.
  • Ames B. N., Shigenaga M. K. and Hagen T. M. (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl Acad. Sci. USA 90, 79157922.
  • Andreasen N., Minthon L., Vanmechelen E., Vanderstichele H., Davidsson P., Winblad B. and Blennow K. (1999) Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment. Neurosci. Lett. 273, 58.
  • Birincioglu M., Jaruga P., Chowdhury G., Rodriguez H., Dizdaroglu M. and Gates K. S. (2003) DNA base damage by the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine). J. Am. Chem. Soc. 125, 11 60711 615.
  • Braak H. and Braak E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.) 82, 239259.
  • Breen A. P. and Murphy J. A. (1995) Reactions of oxyl radicals with DNA. Free Radic. Biol. Med. 18, 10331077.
  • Bruce-Keller A. J., Li Y. J., Lovell M. A., Kraemer P. J., Gary D. S., Brown R. R., Markesbery W. R. and Mattson M. P. (1998) 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J. Neuropathol. Exp. Neurol. 57, 257267.
  • Chen D., Cao G., Hastings T., Feng Y., Pei W., O'Horo C. and Chen J. (2002) Age-dependent decline of DNA repair activity for oxidative lesions in rat brain mitochondria. J. Neurochem. 81, 12731284.
  • Chen Q., Ding Q., Thorpe J., Dohmen R. J. and Keller J. N. (2005) RNA interference toward UMP1 induces proteasome inhibition in Saccharomyces cerevisiae: evidence for protein oxidation and autophagic cell death. Free Radic. Biol. Med. 38, 226234.
  • Cooke M. S., Evans M. D., Dizdaroglu M. and Lunec J. (2003) Oxidative DNA damage: mechanisms, mutation, and disease. Faseb J. 17, 11951214.
  • Cornett C. R., Markesbery W. R. and Ehmann W. D. (1998) Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology 19, 339345.
  • Crawford D. R., Suzuki T., Sesay J. and Davies K. J. (2002) Analysis of gene expression following oxidative stress. Meth. Mol. Biol. 196, 155162.
  • Davies K. J. (1995) Oxidative stress: the paradox of aerobic life. Biochem. Soc. Symp. 61, 131.
  • DeCarli C. (2003) Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol. 2, 1521.
  • DeCarli C., Miller B. L., Swan G. E., Reed T., Wolf P. A. and Carmelli D. (2001) Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch. Neurol. 58, 643647.
  • Dizdaroglu M. (1998) Facts about the artifacts in the measurement of oxidative DNA base damage by gas chromatography-mass spectrometry. Free Radic. Res. 29, 551563.
  • Dizdaroglu M., Jaruga P., Birincioglu M. and Rodriguez H. (2002) Free radical-induced damage to DNA: mechanisms and measurement. Free Radic. Biol. Med. 32, 11021115.
  • Englander E. W., Hu Z., Sharma A., Lee H. M., Wu Z. H. and Greeley G. H. (2002) Rat MYH, a glycosylase for repair of oxidatively damaged DNA, has brain-specific isoforms that localize to neuronal mitochondria. J. Neurochem. 83, 14711480.
  • Gabbita S. P., Lovell M. A. and Markesbery W. R. (1998) Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 71, 20342040.
  • Halliwell B. and Dizdaroglu M. (1992) The measurement of oxidative damage to DNA by HPLC and GC/MS techniques. Free Radic. Res. Commun. 16, 7587.
  • Halliwell B. and Gutterridge J. (1989) Free radical in biology and medicine, 2nd Edn. Oxford University Press, New York.
  • Hashiguchi K., Bohr V. A. and De Souza-Pinto N. C. (2004) Oxidative stress and mitochondrial DNA repair: implications for NRTIs induced DNA damage. Mitochondrion 4, 215222.
  • Hensley K., Hall N., Subramaniam R. et al. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 21462156.
  • Herbert K. E., Evans M. D., Finnegan M. T., Farooq S., Mistry N., Podmore I. D., Farmer P. and Lunec J. (1996) A novel HPLC procedure for the analysis of 8-oxoguanine in DNA. Free Radic. Biol. Med. 20, 467472.
  • Higashide S., Morikawa K., Okumura M., Kondo S., Ogata M., Murakami T., Yamashita A., Kanemoto S., Manabe T. and Imaizumi K. (2004) Identification of regulatory cis-acting elements for alternative splicing of presenilin 2 exon 5 under hypoxic stress conditions. J. Neurochem. 91, 11911198.
  • Hirai K., Aliev G., Nunomura A. et al. (2001) Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21, 30173023.
  • Kokmen E., Whisnant J. P., O'Fallon W. M., Chu C. P. and Beard C. M. (1996) Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960–1984). Neurology 46, 154159.
  • De Leon M. J., Convit A., Wolf O. T. et al. (2001) Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc. Natl Acad. Sci. USA 98, 10 96610 971.
  • Lopez O. L., Jagust W. J., Dulberg C. et al. (2003) Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch. Neurol. 60, 13941399.
  • Lovell M. A., Ehmann W. D., Butler S. M. and Markesbery W. R. (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 15941601.
  • Lovell M. A., Ehmann W. D., Mattson M. P. and Markesbery W. R. (1997) Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging 18, 457461.
  • Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L. and Markesbery W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 4752.
  • Lovell M. A., Gabbita S. P. and Markesbery W. R. (1999) Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J. Neurochem. 72, 771776.
  • Lovell M. A., Xie C. and Markesbery W. R. (2000a) Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radic. Biol. Med. 29, 714720.
  • Lovell M. A., Xie C. and Markesbery W. R. (2000b) Decreased base excision repair and increased helicase activity in Alzheimer's disease brain. Brain Res. 855, 116123.
  • Lovell M. A., Xie C. and Markesbery W. R. (2001) Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 22, 187194.
  • Lovell M. A., Robertson J. D., Buchholz B. A., Xie C. and Markesbery W. R. (2002) Use of bomb pulse carbon-14 to age senile plaques and neurofibrillary tangles in Alzheimer's disease. Neurobiol. Aging 23, 179186.
  • Lyras L., Cairns N. J., Jenner A., Jenner P. and Halliwell B. (1997) An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68, 20612069.
  • Markesbery W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134147.
  • Markesbery W. R. and Carney J. M. (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol. 9, 133146.
  • Markesbery W. R. and Lovell M. A. (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19, 3336.
  • Markesbery W. R., Schmitt F. A. and Kryscio R. J. (2006) The neuropathologic substrate of mild cognitive impairment. Arch. Neurol. in press.
  • Mecocci P., MacGarvey U., Kaufman A. E., Koontz D., Shoffner J. M., Wallace D. C. and Beal M. F. (1993) Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34, 609616.
  • Mecocci P., MacGarvey U. and Beal M. F. (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36, 747751.
  • Migliore L., Fontana I., Trippi F., Colognato R., Coppede F., Tognoni G., Nucciarone B. and Siciliano G. (2005) Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol. Aging 26, 567573.
  • Morris J. C., Heyman A., Mohs R. C., Hughes J. P., Van Belle G., Fillenbaum G., Mellits E. D. and Clark C. (1989) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39, 11591165.
  • Nacmias B., Piccini C., Bagnoli S., Tedde A., Cellini E., Bracco L. and Sorbi S. (2004) Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease. Neurosci. Lett. 367, 379383.
  • Okamura N., Arai H., Maruyama M. et al. (2002) Combined analysis of CSF tau levels and [123,I]iodoamphetamine SPECT in mild cognitive impairment: Implications for a novel predictor of Alzheimer's disease. Am. J. Psychiat. 159, 474476.
  • Petersen R. C., Smith G. E., Waring S. C., Ivnik R. J., Tangalos E. G. and Kokmen E. (1999) Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56, 303308.
  • Poon H. F., Castegna A., Farr S. A., Thongboonkerd V., Lynn B. C., Banks W. A., Morley J. E., Klein J. B. and Butterfield D. A. (2004) Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain. Neuroscience 126, 915926.
  • Pratico D., Clark C. M., Liun F., Rokach J., Lee V. Y. and Trojanowski J. Q. (2002) Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch. Neurol. 59, 972976.
  • Smith C. D., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A. and Markesbery W. R. (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl Acad. Sci. USA 88, 10 54010 543.
  • Smith I. F., Boyle J. P., Green K. N., Pearson H. A. and Peers C. (2004) Hypoxic remodelling of Ca2+ mobilization in type I cortical astrocytes: involvement of ROS and pro-amyloidogenic APP processing. J. Neurochem. 88, 869877.
  • Steenken S. (1989) Purine bases, nucleosides, and nucleotides: aqueous solution redox chemistry and transformation reaction of their radical cations and e and OH adducts. Chem. Rev. 89, 503520.
  • Stuart J. A., Mayard S., Hashiguchi K., Souza-Pinto N. C. and Bohr V. A. (2005) Localization of mitochondrial DNA base excision repair to an inner membrane-associated particulate fraction. Nucl. Acids Res. 33, 37223732.
  • Tatemichi T. K., Paik M., Bagiella E., Desmond D. W., Pirro M. and Hanzawa L. K. (1994) Dementia after stroke is a predictor of long-term survival. Stroke 25, 19151919.
  • Traykov L., Rigaud A. S., Baudic S., Smagghe A., Boller F. and Forette F. (2002) Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease. J. Neurol. Sci. 203–204, 177181.
  • Wallace D. C. (1992) Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256, 628632.
  • Wallace D. C. (1999) Mitochondrial diseases in man and mouse. Science 283, 14821488.
  • Wang J., Xiong S., Xie C., Markesbery W. R. and Lovell M. A. (2005) Increased oxidative damage in nuclear and mithochondrial DNA in Alzheimer's disease. J. Neurochem. 93, 953962.
  • Wolf H., Hensel A., Kruggel F., Riedel-Heller S. G., Arendt T., Wahlund L. O. and Gertz H. J. (2004) Structural correlates of mild cognitive impairment. Neurobiol. Aging 25, 913924.
  • Xie C. X., Mattson M. P., Lovell M. A. and Yokel R. A. (1996) Intraneuronal aluminum potentiates iron-induced oxidative stress in cultured rat hippocampal neurons. Brain Res. 743, 271277.